Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation

Rima M. Saliba, Uri Greenbaum, Qing Ma, Samer A. Srour, Yudith Carmazzi, Liang Li, Betul Oran, Michael Moller, Janet Wood, Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, David Partlow, Dan Li, Katayoun Rezvani, Elizabeth J. Shpall, Kai Cao, Richard E. Champlin, Jun Zou

Blood Adv (2021) 5 (17): 3407–3417.

https://doi.org/10.1182/bloodadvances.2021004307

Published: 2021

Includes: Supplemental data

Journal Articles

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Stéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Dominik Heim, Jörg Halter, Gayathri Nair, Yves Chalandon, Urs Schanz, Tayfun Güngör, Grazia Nicoloso, Jakob R. Passweg, Jean Villard, on behalf of the Swiss Blood Stem Cell Transplantation Group

Blood Adv (2021) 5 (17): 3377–3386.

https://doi.org/10.1182/bloodadvances.2020003998

Published: 2021

Includes: Supplemental data

Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Blood Adv (2021) 5 (17): 3309–3321.

https://doi.org/10.1182/bloodadvances.2021004456

Published: 2021

Includes: Supplemental data

Journal Articles

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Blood Adv (2021) 5 (17): 3290–3302.

https://doi.org/10.1182/bloodadvances.2020003669

Published: 2021

Includes: Supplemental data

Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura

Blood Adv (2021) 5 (12): 2650–2659.

https://doi.org/10.1182/bloodadvances.2021004192

Published: 2021

Includes: Supplemental data

Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak

Blood Adv (2021) 5 (8): 2106–2114.

https://doi.org/10.1182/bloodadvances.2020003988

Published: 2021

Includes: Supplemental data

Journal Articles

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML

Brian C. Shaffer, Jean-Benoit Le Luduec, Soo Park, Sean Devlin, Anne Archer, Eric Davis, Candice Cooper, Melissa Nhaissi, Beth Suri, Deborah Wells, Roni Tamari, Esperanza Papadopoulos, Ann A. Jakubowski, Sergio Giralt, Katharine C. Hsu

Blood Adv (2021) 5 (7): 2003–2011.

https://doi.org/10.1182/bloodadvances.2020002701

Published: 2021

Includes: Supplemental data

Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar

Blood Adv (2021) 5 (5): 1425–1436.

https://doi.org/10.1182/bloodadvances.2020003219

Published: 2021

Includes: Supplemental data

Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli

Blood Adv (2021) 5 (5): 1333–1339.

https://doi.org/10.1182/bloodadvances.2020003707

Published: 2021

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors

Blood Adv (2021) 5 (4): 975–983.

https://doi.org/10.1182/bloodadvances.2020003654

Published: 2021

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley

Blood Adv (2020) 4 (19): 4980.

https://doi.org/10.1182/bloodadvances.2020001888

Published: 2020

Includes: Supplemental data

Journal Articles

Stable HLA antibodies following sustained CD19 + cell depletion implicate a long-lived plasma cell source

Zheng Zhang, Stephen J. Schuster, Simon F. Lacey, Michael C. Milone, Dimitri Monos, Vijay G. Bhoj

Blood Adv (2020) 4 (18): 4292–4295.

https://doi.org/10.1182/bloodadvances.2020002435

Published: 2020

Journal Articles

Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.

Blood Adv (2020) 4 (16): 3926.

https://doi.org/10.1182/bloodadvances.2020003085

Published: 2020

Journal Articles

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge

Blood Adv (2020) 4 (16): 3927–3942.

https://doi.org/10.1182/bloodadvances.2019001032

Published: 2020

Includes: Supplemental data

Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy

Blood Adv (2020) 4 (16): 3894–3899.

https://doi.org/10.1182/bloodadvances.2020002236

Published: 2020

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

Development and validation of a universal blood donor genotyping platform: a multinational prospective study

Blood Adv (2020) 4 (15): 3495–3506.

https://doi.org/10.1182/bloodadvances.2020001894

Published: 2020

Includes: Supplemental data

NARROW

Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Naive T-cell depletion in stem cell transplantation

Stable HLA antibodies following sustained CD19 + cell depletion implicate a long-lived plasma cell source

Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Development and validation of a universal blood donor genotyping platform: a multinational prospective study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only